Can a PSEN2 Genetic Test Rule Out Alzheimer’s or Other Dementias?

Learn why a negative PSEN2 result leaves most dementia risk unchanged and what family-history steps help clarify it.

No. A PSEN2 genetic test cannot rule out Alzheimer's disease or other dementias.

PSEN2 is a rare gene linked to inherited early-onset Alzheimer's, and most dementia occurs without it. A negative result leaves common risks in place. A positive result also does not perfectly predict when symptoms start or how they progress.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

What does PSEN2 testing detect?

PSEN2 is one of three rare deterministic genes, along with APP and PSEN1, that can cause autosomal-dominant early-onset familial Alzheimer's disease. Symptoms in these families typically begin before age 65. The National Institute on Aging describes this inheritance pattern in its Alzheimer's Disease Genetics Fact Sheet.

PSEN2 is the rarest of the three. MedlinePlus Genetics reports at least 11 PSEN2 mutations that cause early-onset Alzheimer's, accounting for less than 5% of early-onset cases, in its PSEN2 gene page. A child of a carrier has a 50/50 chance of inheriting the variant. Inheritance carries a very strong probability of Alzheimer's before age 65.

Why doesn't a negative result clear you?

Most Alzheimer's is common late-onset sporadic disease after age 65. There, APOE-e4 dose is the major established risk factor, not PSEN2. People without PSEN2 mutations therefore remain at risk.

A negative PSEN1, PSEN2, or APP result is especially ambiguous when the family mutation is unknown. Joint guidelines from the American College of Medical Genetics and National Society of Genetic Counselors warn that such a result does not exclude a genetic contribution. Only testing for a known family variant can clarify individual risk. Without that anchor, other genes, shared risks, and new variants may still matter.

What other dementias are unrelated to PSEN2?

Dementia is an umbrella term, not one disease. It also includes vascular dementia, Lewy body dementia, frontotemporal dementia, and mixed disease. These conditions involve different vascular or protein causes.

A PSEN2 result says nothing about stroke-related injury, Lewy-body proteins, or frontotemporal degeneration. That distinction matters for symptoms and care. Memory loss can come from blood-flow damage, movement-linked Lewy disease, behavior-linked frontotemporal disease, or more than one process at once.

What should you do with family-history concern?

Start with medical evaluation, not a direct-to-consumer gene test alone. People with early-onset family history should use pre- and post-test genetic counseling plus clinical and biomarker evaluation.

Bring what you can to the visit: If a relative carries a known variant, targeted testing of that exact variant is the clearest next step. If no variant is known, a clinician can advise whether broader workup, brain imaging, lab tests, or referral fits better than PSEN2 testing alone.

  • ages when relatives developed memory, thinking, behavior, or movement changes
  • whether any relative had confirmed APP, PSEN1, or PSEN2 testing
  • your own memory, mood, sleep, vascular, medication, and head-injury history

You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.